SELLAS Life Sciences Group, Inc. — Director's Dealing 2013

Dec 13, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2013-11-12

Reporting Person: Hillsberg Sanford (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-12	Common Stock	G	37001	—	Disposed	93375	Indirect
2013-12-12	Common Stock	M	50000	$0.72	Acquired	143375	Indirect
2013-12-12	Common Stock	F	8592	$4.19	Disposed	134873	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-12	Stock Option	$0.72	M	50000	Disposed	2022-01-12	Common Stock (50000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17974	Direct

Footnotes

F1: Charitable gift donation.

F2: The option vested in equal quarterly installments of 12,500 shares on each of April 12, 2012, July 12, 2012, October 12, 2012 and January 12, 2013.